Clinical Development and Medical Affairs
Novartis is reimagining medicine through research and innovation.
Explore our resources for you and your patients.
AML = acute myeloid leukemia; MDS = myelodysplastic syndromes; CML = chronic myeloid leukemia; PROS = PIK3CA-related overgrowth spectrum.